Kevin Yarasheski

Dr. Yarasheski obtained the PhD in physiology from Kent State University and completed a three-year post-doctoral research fellowship in geriatrics, metabolism and endocrinology at Washington University School of Medicine. For 29+ years, Dr. Yarasheski remained in the Department of Internal Medicine at Washington University School of Medicine where he rose to the rank of tenured Full Professor, co-Directed the Biomedical Mass Spectrometry Research Facility, fully supported his independent mass spectrometry-based clinical research program, and collaborated with Drs. Bateman, West and Holtzman on their Alzheimer's disease projects that required mass spectrometry analysis. Dr. Yarasheski also conducted translational clinical research focused on using gas or liquid chromatography-mass spectrometry to detect, characterize and quantify biomolecules present in human biofluids and tissues, and that revealed underlying alterations in protein and amino acid metabolism that contributed to the pathogenesis of several conditions: unsuccessful aging, cachexia, malnutrition, and cardiometabolic complications. In 2016, Dr. Yarasheski joined C₂N Diagnostics as Senior Vice President where he directs and supervises laboratory personnel and mass spectrometry research, development and discovery efforts focused on biomarkers for neurodegeneration and AD pathology.